DPPIV

DPPIV

DPPIV 詳細

Molecule Name
Dipeptidyl peptidase IV
分子の別称
DPP4,ADABP,ADCP2,CD26,DPPIV,TP103
Drug Development Progress
治験薬の数37
市販薬剤の数42
研究&開発段階Approved
ターゲットの別称
Dipeptidyl peptidase IV membrane form,T-cell activation antigen CD26,Adenosine deaminase complexing protein 2,Dipeptidyl peptidase IV,Dipeptidyl peptidase IV soluble form,ADCP2,Dipeptidyl peptidase 4,ADCP-2,ADABP,DPP4,Dipeptidylpeptidase IV (CD26, Adenosine Deaminase Complexing Protein 2),DPP IV,TP103,CD26,Dipeptidyl-Peptidase 4,Dipeptidylpeptidase 4,CD26 Antigen,DPPIV,Xaa-Pro-Dipeptidylaminopeptidase,Gly-Pro Naphthylamidase,Post-Proline Dipeptidyl Aminopeptidase IV
バックグランド
Dipeptidyl peptidase-IV (DPPIV) is also known as adenosine deaminase complexing protein 2, DPPIV or CD26 is antigenic enzyme expressed on the surface of most cell types and is associated with immune regulation, signal transduction and apoptosis. It is an intrinsic membrane glycoprotein and a serine exopeptidase that cleaves X-proline dipeptides from the N-terminus of polypeptides. The substrates of DPPIV are proline (or alanine)-containing peptides and include growth factors, chemokines, neuropeptides, and vasoactive peptides. DPPIV plays a major role in glucose metabolism. It is responsible for the degradation of incretins such as GLP-1. DPPIV plays an important role in tumor biology, and is useful as a marker for various cancers, with its levels either on the cell surface or in the serum increased in some neoplasms and decreased in others. DPPIV also binds the enzyme adenosine deaminase specifically and with high affinity. The significance of this interaction has yet to be established.

DPPIV 製品リスト

Species
  • Human(4)
  • Canine(1)
  • Cynomolgus(1)
  • Mouse(1)
Tag
  • His Tag(4)
  • Fc Tag(1)
  • His Tag & Avi Tag(1)
  • Tag Free(1)
Host
  • HEK293(7)
Conjugate
  • Unconjugated(6)
  • Biotin-labeled(1)
Grade
  • RUO(7)
Low Endotoxin
  • Yes(1)
  • No(6)
You Have Viewed 1-7 Of 7 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
Dutogliptin TartrateREC-01; PHX-1149; PHX-1149TPhase 3 ClinicalPhenomix
Diabetes Mellitus, Type 2; Leukemia, Myeloid, Acute; Myocardial Infarction; Renal Insufficiency; ST Elevation Myocardial Infarction
詳細
YogliptinPhase 3 ClinicalChengdu Easton Biopharmaceuticals Co Ltd, Sichuan Sunheal Pharmaceutical Co Ltd
Diabetes Mellitus, Type 2
詳細
Empagliflozin/Sitagliptin HydrochlorideDW1026C1; DW-1026C1; DW1026C2; DW-1026C2Phase 3 ClinicalDaewon Pharmaceutical Co Ltd
Diabetes Mellitus, Type 2
詳細
Dapagliflozin formate/LinagliptinIN-C009; AJU-A51Phase 3 ClinicalAju Pharm Co Ltd, HK inno.N Corporation
Diabetes Mellitus, Type 2
詳細
DA5221-B2DA5221-B2Phase 3 ClinicalDong-A ST Co Ltd
Diabetes Mellitus, Type 2
詳細
LID104LID104; LID-104Phase 3 ClinicalEms
Diabetes Mellitus, Type 2
詳細
Empagliflozin/Metformin/Sitagliptin (Chong Kun Dang Pharmaceutical)CKD-379Phase 3 ClinicalChong Kun Dang Pharmaceutical Corp
Diabetes Mellitus; Diabetes Mellitus, Type 2
詳細
TOTUM•63TOTUM-63Phase 3 ClinicalValbiotis
Diabetes Mellitus, Type 2
詳細
TalabostatVbP; PT-100; BXCL-701Phase 2 ClinicalPoint Therapeutics
Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Small Cell; CNS Embryonal Tumor; Kidney Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Liver Neoplasms; Lung Neoplasms; Melanoma; Myelodysplastic Syndromes; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Neuroblastoma; Neuroendocrine Tumors; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Sarcoma; Skin Neoplasms; Solid tumours
詳細
TQ-F3083TQ-F3083; CT-383Phase 2 ClinicalBeijing Centaurus Biopharma Co Ltd, Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd
Diabetes Mellitus; Diabetes Mellitus, Type 2
詳細
BegelomabSAND-26; BT 5/9Phase 2 ClinicalAdienne
Dermatomyositis; Graft vs Host Disease
詳細
SingletineDC-291407; DC-407; DC291407Phase 2 ClinicalCisen Pharmaceutical Co Ltd, Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences
Diabetes Mellitus, Type 2; Fatty Liver
詳細
GCP-002EP-HMRGPhase 2 ClinicalGoryo Chemical Inc
Esophageal Neoplasms
詳細
Metformin/Dapagliflozin/SitagliptinGMRx4Phase 2 ClinicalGeorge Medicines PTY Ltd, George Medicines UK Ltd
Diabetes Mellitus, Type 2
詳細
Bogliptin maleateHL012MAPhase 2 ClinicalEast China University Of Science And Technology, Shandong Baiji Dichang Pharmaceutical Co Ltd, Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences
Diabetes Mellitus, Type 2
詳細
CKD-393CKD-393Phase 1 ClinicalChong Kun Dang Pharmaceutical Corp
Diabetes Mellitus, Type 2
詳細
Augliptin HydrochloridePhase 1 ClinicalNanjing Changao Pharmaceutical Science And Technologyco Ltd, Shanghai Sun-Sail Pharmaceutical Science & Technology Co Ltd
Diabetes Mellitus, Type 2
詳細
Evogliptin TartrateLY-05007Phase 1 ClinicalDong-A Pharmaceutical Co Ltd
Diabetes Mellitus, Type 2
詳細
Sitagliptin/TelmisartanHDDO-16091 + HDDO-16092; HOB-077; HDDO-1609Phase 1 ClinicalHyundai Pharmaceutical Co Ltd
Diabetes Mellitus; Hypertension
詳細
TSL-0319TSL-0319Phase 1 ClinicalJiangsu Tasly Diyi Pharmaceutical Co Ltd
Diabetes Mellitus, Type 2
詳細
Prusogliptin/Dapagliflozin/MetforminPhase 1 ClinicalCspc Ouyi Pharmaceutical Co Ltd
Diabetes Mellitus, Type 2
詳細
Vildagliptin and Metformin Hydrochloride Extended-Release Tablets(24h)(Taizhou Overseas Pharma)Phase 1 ClinicalTaizhou Overseas Pharmaceuticals Co Ltd
Diabetes Mellitus, Type 2
詳細
Vildagliptin and Metformin Hydrochloride Extended-Release Tablets(Taizhou Overseas Pharma)Phase 1 ClinicalTaizhou Overseas Pharmaceuticals Co Ltd
Diabetes Mellitus, Type 2
詳細
Alogliptin and Metformin Hydrochloride Sustained-release Tablets(Taizhou Overseas Pharma)Phase 1 ClinicalTaizhou Overseas Pharmaceuticals Co Ltd
Diabetes Mellitus, Type 2
詳細
CTL-02CTL-02; CTL02Phase 1 ClinicalCelltrion Inc
詳細
Vildagliptin Sustained-release Tablets(Taizhou Overseas Pharma)Phase 1 ClinicalTaizhou Overseas Pharmaceuticals Co Ltd
Diabetes Mellitus, Type 2
詳細
AJU-A53AJU-A53Phase 1 ClinicalAju Pharm Co Ltd
Diabetes Mellitus, Type 2
詳細
CKD-393(2)CKD-393(2)Phase 1 ClinicalChong Kun Dang Pharmaceutical Corp
Diabetes Mellitus, Type 2
詳細
ZHB-015ZHB-015; ZHB015; ZHB-C003Phase 1 ClinicalZonhon Biopharma Institute Inc
Solid tumours
詳細
CMR-316CMR316; CMR-316Phase 1 ClinicalThe Calibr-Skaggs Institute for Innovative Medicines
Idiopathic Pulmonary Fibrosis; Pulmonary Disease, Chronic Obstructive; Respiratory Distress Syndrome, Adult
詳細
Vildagliptin/Empagliflozin/Metformin HydrochloridePhase 1 ClinicalTaizhou Overseas Pharmaceuticals Co Ltd
Diabetes Mellitus; Diabetes Mellitus, Type 2
詳細
CGT-2201CGT-2201Phase 1 ClinicalCgenetech(Suzhou China) Co Ltd
Diabetes Mellitus; Diabetes Mellitus, Type 2
詳細
Empagliflozin/Metformin/Sitagliptin (Overseas Pharmaceuticals)Phase 1 ClinicalTaizhou Overseas Pharmaceuticals Co Ltd
Diabetes Mellitus, Type 2
詳細
THDBH-100THDBH100; THDBH101Phase 1 ClinicalWuxi Apptec(Shanghai) Co Ltd
Diabetes Mellitus, Type 2
詳細
WXSHC-071WXSHC-071Phase 1 ClinicalDongbao Zixing (Hangzhou) Biological Medicine Co Ltd
Diabetes Mellitus, Type 2
詳細
REC-04ClinicalRecardio Inc
Cardiovascular Diseases
詳細
DASH inhibitor (Bach)ClinicalBach Biosciences LLC
Neoplasms
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
Gemigliptin L-tartrate SesquihydrateLC-150444; LC-15-0444ApprovedLg Chemical LtdGemiglo, ZemigloSouth KoreaDiabetes Mellitus, Type 2Lg Chemical Ltd2012-06-27
Diabetes Mellitus, Type 2; Fasting; Hepatic Insufficiency
詳細
Gemigliptin L-tartrate Sesquihydrate/Metformin HydrochlorideApprovedLg Chemical LtdZemiMet SRSouth KoreaDiabetes Mellitus, Type 2Lg Chemical Ltd2015-01-01
Diabetes Mellitus, Type 2
詳細
Teneligliptin Hydrobromide Hydrate/Metformin HydrochlorideApprovedHandok IncTenelia M SRSouth KoreaDiabetes Mellitus, Type 2Handok Inc2015-11-03
Diabetes Mellitus, Type 2
詳細
EvogliptinDA-1229; RNV-1001ApprovedDong-A Pharmaceutical Co LtdSugarnon, Evodine, Suganon, SUGANONSouth KoreaDiabetes Mellitus, Type 2Dong-A Pharmaceutical Co Ltd2015-10-02
Aortic valve diseases; Diabetes Mellitus, Type 2; Liver Dysfunction; Renal Insufficiency
詳細
Saxagliptin HydrateBMS-477118; BMS-477118-11; OPC-262ApprovedBristol-Myers Squibb Company安立泽, OnglyzaEUDiabetes Mellitus, Type 2Astrazeneca Ab2009-07-31
Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Hypoglycemia
詳細
Teneligliptin Hydrobromide HydrateMP-513ApprovedMitsubishi Tanabe PharmaTenglyn, TeneliaJapanDiabetes Mellitus, Type 2Mitsubishi Tanabe Pharma, Daiichi Sankyo Co Ltd2012-06-29
Diabetes Mellitus, Type 2
詳細
Retagliptin PhosphateSP-2086 Phosphate; SP 2086ApprovedJiangsu Hengrui Medicine Co Ltd瑞泽唐Mainland ChinaDiabetes Mellitus, Type 2Jiangsu Hengrui Medicine Co Ltd2023-06-27
Diabetes Mellitus; Diabetes Mellitus, Type 2; Renal Insufficiency
詳細
Sitagliptin Phosphate Monohydrate/Ipragliflozin L-ProlineMK-0431JApprovedAstellas Pharma Inc, Merck & Co IncSujanuJapanDiabetes Mellitus, Type 2null2018-03-23
Diabetes Mellitus, Type 2
詳細
PrusogliptinDBPR-108ApprovedNational Health Research Institutes, Taiwan Shenlong Co Ltd善泽平Mainland ChinaDiabetes Mellitus, Type 2Cspc Ouyi Pharmaceutical Co Ltd2025-01-08
Diabetes Mellitus, Type 2; Hepatic Insufficiency; Renal Insufficiency
詳細
LinagliptinBI-1356; BI-1356-BSApprovedBoehringer Ingelheim International Gmbh欧唐宁, Ondero, Trajenta, Trayenta, Trazenta, TradjentaUnited StatesDiabetes Mellitus, Type 2Boehringer Ingelheim International Gmbh2011-05-02
Albuminuria; Coronavirus Disease 2019 (COVID-19); Coronavirus Infections; Diabetes Mellitus; Diabetes Mellitus, Type 2; Endocrine System Diseases; Glucose Metabolism Disorders; Hepatic Insufficiency; Hyperglycemia; Hypertension; Inflammation; Metabolic Diseases; Prediabetic State; Renal Insufficiency; Respiratory Tract Diseases; Schizophrenia; Ventricular Dysfunction, Left
詳細
Rosuvastatin Calcium/Gemigliptin L-tartrate SesquihydrateApprovedLg Chemical LtdZemiStatinSouth KoreaDiabetes Mellitus, Type 2; DyslipidemiasLg Chemical Ltd2017-07-31
Diabetes Mellitus, Type 2; Dyslipidemias
詳細
Alogliptin BenzoateSYR-322; TAK-322ApprovedTakeda Pharmaceutical Co LtdNesina, 尼欣那, VipidiaJapanDiabetes Mellitus, Type 2Takeda Pharmaceutical Co Ltd2010-04-06
Acute Coronary Syndrome; Diabetes Mellitus; Diabetes Mellitus, Type 2
詳細
Empagliflozin/Linagliptin/MetforminApprovedBoehringer Ingelheim International Gmbh, Eli Lilly And CompanyTrijardy XRUnited StatesDiabetes Mellitus, Type 2Boehringer Ingelheim International Gmbh2020-01-27
Diabetes Mellitus, Type 2
詳細
Sitagliptin Phosphate/Metformin HydrochlorideApprovedMerck & Co IncVelmetia, Janumet, 捷诺达United StatesDiabetes Mellitus, Type 2Merck & Co Inc2007-03-30
Diabetes Mellitus, Type 2
詳細
Teneligliptin Hydrobromide Hydrate/Canagliflozin HemihydrateApprovedDaiichi Sankyo Co Ltd, Mitsubishi Tanabe Pharma CorpCanaliaJapanDiabetes Mellitus, Type 2Daiichi Sankyo Co Ltd, Mitsubishi Tanabe Pharma2017-07-03
Diabetes Mellitus, Type 2
詳細
Anagliptin/Metformin HydrochlorideSK-1501ApprovedSanwa Kagaku Kenkyusho Co Ltd, SuzukenMetoanaJapanDiabetes Mellitus, Type 2Sanwa Kagaku Kenkyusho Co Ltd2018-09-21
Diabetes Mellitus, Type 2
詳細
Vildagliptin/Metformin HydrochlorideLMF-237ApprovedNovartis Pharma Ag宜合瑞, Eucreas, EquMet, Zomarist, Icandra, GalvusmetEUDiabetes Mellitus, Type 2Novartis Europharm Ltd2007-11-14
Diabetes Mellitus, Type 2
詳細
Sentagliptin PhosphateCGT-8012ApprovedCgenetech(Suzhou China) Co Ltd盛捷维Mainland ChinaDiabetes Mellitus, Type 2Cgenetech(Suzhou China) Co Ltd2024-12-01
Diabetes Mellitus, Type 2
詳細
Alogliptin Benzoate/Metformin HydrochlorideCT-L01; CT-L-01ApprovedTakeda Pharmaceutical Co LtdVipdomet, Inisync, KazanoUnited StatesDiabetes Mellitus, Type 2Takeda Pharmaceuticals USA Inc2013-01-25
Diabetes Mellitus, Type 2
詳細
Fultagliptin BenzoateFCN-005; SAL067; SAL-067Approved信立汀Mainland ChinaDiabetes Mellitus, Type 2Shenzhen Salubris Pharmaceuticals Co Ltd2024-06-28
Diabetes Mellitus, Type 2; Renal Insufficiency
詳細
CofrogliptinHSK7653; HSK-7653ApprovedLiaoning Haisco Pharmaceutical Co Ltd, Sichuan Haisco Pharmaceutical Co Ltd倍长平Mainland ChinaDiabetes Mellitus, Type 2Haisco Pharmaceutical Group Co Ltd2024-06-18
Diabetes Mellitus, Type 2; Glucose Intolerance; Renal Insufficiency
詳細
AnagliptinSK-0403; CWP-0403ApprovedSanwa Kagaku Kenkyusho Co LtdSuiny, BeskoaJapanDiabetes Mellitus, Type 2null2012-09-28
Diabetes Mellitus, Type 2
詳細
Dapagliflozin Propanediol Monohydrate/Saxagliptin HydrochlorideApprovedAstrazeneca PlcQternEUDiabetes Mellitus, Type 2Astrazeneca Ab2016-07-15
Diabetes Mellitus, Type 2
詳細
Alogliptin Benzoate/Pioglitazone HydrochlorideSYR-322-4833 BLApprovedTakeda Pharmaceutical Co LtdNesinaact, Oseni, Liovel, IncresyncJapanDiabetes Mellitus, Type 2Takeda Pharmaceutical Co Ltd2011-07-01
Diabetes Mellitus, Type 2
詳細
Sitagliptin Phosphate MonohydrateONO-5435A; ONO-5435; MK-0431; MK-431; L-000224715ApprovedMerck Sharp & Dohme CorpRistaben, Xelevia, Tesavel, Glactiv, 捷诺维, Januvia, DIABIT-IS XUnited StatesDiabetes Mellitus, Type 2Merck & Co Inc2006-10-16
Atherosclerosis; Carcinoma, Hepatocellular; Cardiovascular Diseases; Coronavirus Disease 2019 (COVID-19); Cystic Fibrosis; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Gastroparesis; Glucose Intolerance; Graft vs Host Disease; Heart Failure; Hepatic Insufficiency; Hepatitis C; HIV Infections; Hyperlipidemias; Inflammation; Insulin Resistance; Kidney Failure, Chronic; Leukemia, Myelogenous, Chronic; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Metabolic Dysfunction-Associated Steatotic Liver Disease; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prediabetic State; Psoriasis; Renal Insufficiency; Renal Insufficiency, Chronic
詳細
Trelagliptin SuccinateTAK-472; SYR-472; SYR-111472; SYR-111472 succinateApprovedTakeda Pharmaceutical Co LtdZafatekJapanDiabetes Mellitus, Type 2Takeda Pharmaceutical Co Ltd2015-03-26
Diabetes Mellitus; Diabetes Mellitus, Type 2
詳細
Evogliptin Tartrate/Metformin HydrochlorideDA-1229_01ApprovedDong-A Pharmaceutical Co LtdSugamet XRSouth KoreaDiabetes Mellitus, Type 2Dong-A Pharmaceutical Co Ltd2015-12-01
Diabetes Mellitus, Type 2
詳細
Sitagliptin/ErtugliflozinApprovedPfizer IncSteglujanUnited StatesDiabetes Mellitus, Type 2Merck & Co Inc2017-12-19
Diabetes Mellitus, Type 2
詳細
Retagliptin Phosphate/Metformin HydrochlorideHRX-0701; HRX0701ApprovedJiangsu Hengrui Medicine Co Ltd瑞霖唐Mainland ChinaDiabetes Mellitus, Type 2Shandong Shengdi Pharmaceutical Co Ltd2025-05-20
Diabetes Mellitus, Type 2
詳細
Sitagliptin/Metformin Hydrochloride (Zydus Lifesciences)ApprovedZydus Lifesciences LtdZituvimet, ZITUVIMETUnited StatesDiabetes Mellitus, Type 2Zydus Lifesciences Ltd2023-11-03
Diabetes Mellitus, Type 2
詳細
OmarigliptinMK-3102ApprovedMerck & Co IncMarizevJapanDiabetes Mellitus, Type 2Merck Sharp & Dohme Corp2015-09-28
Diabetes Mellitus; Diabetes Mellitus, Type 2; Renal Insufficiency, Chronic
詳細
Henagliflozin/metformin/retagliptin (Shandong Shengdi)HR20031; HR-20031ApprovedShandong Shengdi Pharmaceutical Co Ltd瑞乐唐Mainland ChinaDiabetes Mellitus; Diabetes Mellitus, Type 2Shandong Shengdi Pharmaceutical Co Ltd2025-10-21
Diabetes Mellitus; Diabetes Mellitus, Type 2
詳細
Teneligliptin/PioglitazoneApprovedGlenmark Pharmaceuticals LtdZita Plus PioIndiaDiabetes Mellitus, Type 2Glenmark Pharmaceuticals Ltd2022-04-25
Diabetes Mellitus, Type 2
詳細
Dapagliflozin Propanediol Hydrate/Sitagliptin Phosphate HydrateSID-1903; DW-6012ApprovedDong Wha Pharm Co LtdSidapviaSouth KoreaDiabetes Mellitus, Type 2Dong Wha Pharm Co Ltd2023-06-30
Diabetes Mellitus, Type 2; Myocardial Infarction; ST Elevation Myocardial Infarction
詳細
Metformin Hydrochloride/Sitagliptin HydrochlorideApprovedSandoz BvEUSandoz Bv2019-12-10
詳細
Sitagliptin TartrateApprovedHeumann Pharma GmbH & Co Generica KGSitagliptin Heumann 25 mg FilmtablettenEUHeumann Pharma GmbH & Co Generica KG2020-12-14
Diabetes Mellitus, Type 1; Diabetic Nephropathies; Metabolic Dysfunction-Associated Steatotic Liver Disease; Parkinson Disease
詳細
Sitagliptin HydrochlorideApprovedLaboratorios Alter SaSpainDiabetes Mellitus, Type 2Laboratorios Alter Sa2019-03-06
Diabetes Mellitus, Type 2; Polycystic Ovary Syndrome
詳細
Gemigliptin/DapagliflozinApprovedLg Chemical LtdZemidapaSouth KoreaDiabetes Mellitus, Type 2Lg Chemical Ltd2022-06-21
Diabetes Mellitus, Type 2
詳細
Linagliptin/Metformin HydrochlorideGC2129A; GC-2129-A; DW6013ApprovedBoehringer Ingelheim International GmbhJentadueto Xr, Trajenta Duo, Jentadueto, 欧双宁United StatesDiabetes Mellitus, Type 2Boehringer Ingelheim International Gmbh2012-01-30
Diabetes Mellitus, Type 2
詳細
Linagliptin/EmpagliflozinBI 1356/BI 10773; BI 10773/linagliptin; BI 1356/empagliflozin; Empagliflozin/BI 1356; Linagliptin/BI 10773; BI 10773/BI 1356ApprovedC.H. Boehringer Sohn Ag & Co. KgTradiance, Glyxambi, EsgliteoUnited StatesDiabetes Mellitus, Type 2Boehringer Ingelheim International Gmbh2015-01-30
Cardiovascular Diseases; Diabetes Mellitus, Type 2
詳細
VildagliptinLAF-237; DSP-7238; LAF-237A; NVP-LAF-237ApprovedNovartis Pharma Ag佳维乐, Equa, Jalra, Galvus, Gliptus, XiliarxEUDiabetes Mellitus, Type 2Novartis Europharm Ltd2007-09-25
Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes, Gestational; Dyslipidemias; Insulin Resistance; Prediabetic State; Renal Insufficiency; Schizophrenia
詳細
Saxagliptin Hydrochloride/Metformin HydrochlorideApprovedAstrazeneca Plc安立格, Kombiglyze Xr, KomboglyzeEUDiabetes Mellitus, Type 2Astrazeneca Ab2010-11-05
Diabetes Mellitus, Type 2
詳細
Customer Reviews